Comparison of treatments of chronic hepatitis B in children with lamivudine and alpha-interferon combination and alpha-interferon alone (Q58003637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

title

Comparison of treatments of chronic hepatitis B in children with lamivudine and alpha-interferon combination and alpha-interferon alone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Mehmet Bosnak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

Vuslat Bosnak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

Abdullah Dagli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

Mehmet Davutoglu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

Rasit Vural Yagci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

Kenan Haspolat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

published in

Pediatrics International

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

517-521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

Treatment of chronic hepatitis B: new antiviral therapies.

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Chronic hepatitis B in children. Natural history and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Update on clinical trials in the treatment of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Combination therapy of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Hepatitis B e antigen seroconversion: effects of lamivudine alone or in combination with interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Lamivudine as initial treatment for chronic hepatitis B in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

Treatment of chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-200X.2002.01607.X

10.1046/J.1442-200X.2002.01607.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225552 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference